SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Clarification sought from GlaxoSmithkline Consumer Healthcare

26 Jun 2018 Evaluate

The Exchange has sought clarification from GlaxoSmithkline Consumer Healthcare on June 26, 2018, with reference to news appeared on The Economic Times dated June 26, 2018 quoting ‘Coca-Cola plans to boost muscle with Horlicks buy.’

The above information is a part of company’s filings submitted to BSE.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Varun Beverages 449.35
Nestle 1253.70
Britannia Inds 5652.20
LT Foods 414.70
Hatsun Agro Product 943.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×